The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

M. S. Van Der Veer, M. De Weers, B. Van Kessel, J. M. Bakker, S. Wittebol, P. W H I Parren, H. M. Lokhorst, T. Mutis

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article numbere41
JournalBlood cancer journal
Volume1
Issue number10
DOIs
Publication statusPublished - 1 Oct 2011

Cite this

Van Der Veer, M. S., De Weers, M., Van Kessel, B., Bakker, J. M., Wittebol, S., Parren, P. W. H. I., ... Mutis, T. (2011). The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies. Blood cancer journal, 1(10), [e41]. https://doi.org/10.1038/bcj.2011.42
Van Der Veer, M. S. ; De Weers, M. ; Van Kessel, B. ; Bakker, J. M. ; Wittebol, S. ; Parren, P. W H I ; Lokhorst, H. M. ; Mutis, T. / The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies. In: Blood cancer journal. 2011 ; Vol. 1, No. 10.
@article{c4aa3507e8604e03b425a07b3deb058f,
title = "The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies",
author = "{Van Der Veer}, {M. S.} and {De Weers}, M. and {Van Kessel}, B. and Bakker, {J. M.} and S. Wittebol and Parren, {P. W H I} and Lokhorst, {H. M.} and T. Mutis",
year = "2011",
month = "10",
day = "1",
doi = "10.1038/bcj.2011.42",
language = "English",
volume = "1",
journal = "Blood cancer journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "10",

}

Van Der Veer, MS, De Weers, M, Van Kessel, B, Bakker, JM, Wittebol, S, Parren, PWHI, Lokhorst, HM & Mutis, T 2011, 'The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies' Blood cancer journal, vol. 1, no. 10, e41. https://doi.org/10.1038/bcj.2011.42

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies. / Van Der Veer, M. S.; De Weers, M.; Van Kessel, B.; Bakker, J. M.; Wittebol, S.; Parren, P. W H I; Lokhorst, H. M.; Mutis, T.

In: Blood cancer journal, Vol. 1, No. 10, e41, 01.10.2011.

Research output: Contribution to journalLetterAcademicpeer-review

TY - JOUR

T1 - The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

AU - Van Der Veer, M. S.

AU - De Weers, M.

AU - Van Kessel, B.

AU - Bakker, J. M.

AU - Wittebol, S.

AU - Parren, P. W H I

AU - Lokhorst, H. M.

AU - Mutis, T.

PY - 2011/10/1

Y1 - 2011/10/1

UR - http://www.scopus.com/inward/record.url?scp=84864061825&partnerID=8YFLogxK

U2 - 10.1038/bcj.2011.42

DO - 10.1038/bcj.2011.42

M3 - Letter

VL - 1

JO - Blood cancer journal

JF - Blood cancer journal

SN - 2044-5385

IS - 10

M1 - e41

ER -